Microsoft Corporation
Microsoft Corporation (MSF.DE) Stock Competitors & Peer Comparison
See (MSF.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Software - Infrastructure Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MSF.DE | €459.50 | -0.44% | 3.4T | 37.73 | €12.18 | +0.66% |
| MSF.F | €457.10 | -1.06% | 3.4T | 37.62 | €12.15 | +0.66% |
| ORC.DE | €217.35 | +1.02% | 610.5B | 57.05 | €3.81 | +0.74% |
| PTX.F | €149.78 | +7.83% | 336.8B | 783.26 | €0.19 | N/A |
| ADB.DE | €293.90 | -1.36% | 124.7B | 21.50 | €13.67 | N/A |
| BZF1.DE | €139.80 | -1.55% | 60.4B | 45.99 | €3.04 | N/A |
| SQ3.F | €65.03 | -1.13% | 40B | 18.23 | €3.56 | N/A |
| VRS.DE | €220.40 | +0.82% | 20.6B | 36.31 | €6.07 | +0.30% |
| KKS.F | €76.60 | +2.96% | 14.4B | 8.10 | €9.38 | +4.64% |
| AK3.DE | €95.28 | -1.95% | 14.4B | 31.55 | €3.02 | N/A |
Stock Comparison
MSF.DE vs MSF.F Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, MSF.F has a market cap of 3.4T. Regarding current trading prices, MSF.DE is priced at €459.50, while MSF.F trades at €457.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas MSF.F's P/E ratio is 37.62. In terms of profitability, MSF.DE's ROE is +0.33%, compared to MSF.F's ROE of +0.33%. Regarding short-term risk, MSF.DE is less volatile compared to MSF.F. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check MSF.F's competition here
MSF.DE vs ORC.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, ORC.DE has a market cap of 610.5B. Regarding current trading prices, MSF.DE is priced at €459.50, while ORC.DE trades at €217.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas ORC.DE's P/E ratio is 57.05. In terms of profitability, MSF.DE's ROE is +0.33%, compared to ORC.DE's ROE of +0.81%. Regarding short-term risk, MSF.DE is less volatile compared to ORC.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check ORC.DE's competition here
MSF.DE vs PTX.F Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, PTX.F has a market cap of 336.8B. Regarding current trading prices, MSF.DE is priced at €459.50, while PTX.F trades at €149.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas PTX.F's P/E ratio is 783.26. In terms of profitability, MSF.DE's ROE is +0.33%, compared to PTX.F's ROE of +0.12%. Regarding short-term risk, MSF.DE is less volatile compared to PTX.F. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check PTX.F's competition here
MSF.DE vs ADB.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, ADB.DE has a market cap of 124.7B. Regarding current trading prices, MSF.DE is priced at €459.50, while ADB.DE trades at €293.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas ADB.DE's P/E ratio is 21.50. In terms of profitability, MSF.DE's ROE is +0.33%, compared to ADB.DE's ROE of +0.52%. Regarding short-term risk, MSF.DE is more volatile compared to ADB.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check ADB.DE's competition here
MSF.DE vs BZF1.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, BZF1.DE has a market cap of 60.4B. Regarding current trading prices, MSF.DE is priced at €459.50, while BZF1.DE trades at €139.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas BZF1.DE's P/E ratio is 45.99. In terms of profitability, MSF.DE's ROE is +0.33%, compared to BZF1.DE's ROE of +3.99%. Regarding short-term risk, MSF.DE is more volatile compared to BZF1.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check BZF1.DE's competition here
MSF.DE vs SQ3.F Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, SQ3.F has a market cap of 40B. Regarding current trading prices, MSF.DE is priced at €459.50, while SQ3.F trades at €65.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas SQ3.F's P/E ratio is 18.23. In terms of profitability, MSF.DE's ROE is +0.33%, compared to SQ3.F's ROE of +0.13%. Regarding short-term risk, MSF.DE is less volatile compared to SQ3.F. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check SQ3.F's competition here
MSF.DE vs VRS.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, VRS.DE has a market cap of 20.6B. Regarding current trading prices, MSF.DE is priced at €459.50, while VRS.DE trades at €220.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas VRS.DE's P/E ratio is 36.31. In terms of profitability, MSF.DE's ROE is +0.33%, compared to VRS.DE's ROE of -0.41%. Regarding short-term risk, MSF.DE is less volatile compared to VRS.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check VRS.DE's competition here
MSF.DE vs KKS.F Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, KKS.F has a market cap of 14.4B. Regarding current trading prices, MSF.DE is priced at €459.50, while KKS.F trades at €76.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas KKS.F's P/E ratio is 8.10. In terms of profitability, MSF.DE's ROE is +0.33%, compared to KKS.F's ROE of +0.75%. Regarding short-term risk, MSF.DE is less volatile compared to KKS.F. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check KKS.F's competition here
MSF.DE vs AK3.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, AK3.DE has a market cap of 14.4B. Regarding current trading prices, MSF.DE is priced at €459.50, while AK3.DE trades at €95.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas AK3.DE's P/E ratio is 31.55. In terms of profitability, MSF.DE's ROE is +0.33%, compared to AK3.DE's ROE of +0.11%. Regarding short-term risk, MSF.DE is less volatile compared to AK3.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check AK3.DE's competition here
MSF.DE vs PMTA.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, PMTA.DE has a market cap of 14B. Regarding current trading prices, MSF.DE is priced at €459.50, while PMTA.DE trades at €119.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas PMTA.DE's P/E ratio is 28.21. In terms of profitability, MSF.DE's ROE is +0.33%, compared to PMTA.DE's ROE of +0.13%. Regarding short-term risk, MSF.DE is more volatile compared to PMTA.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check PMTA.DE's competition here
MSF.DE vs IOS.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, IOS.DE has a market cap of 5.5B. Regarding current trading prices, MSF.DE is priced at €459.50, while IOS.DE trades at €40.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas IOS.DE's P/E ratio is 30.53. In terms of profitability, MSF.DE's ROE is +0.33%, compared to IOS.DE's ROE of +1.51%. Regarding short-term risk, MSF.DE is less volatile compared to IOS.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check IOS.DE's competition here
MSF.DE vs 3L7A.F Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, 3L7A.F has a market cap of 4.2B. Regarding current trading prices, MSF.DE is priced at €459.50, while 3L7A.F trades at €121.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas 3L7A.F's P/E ratio is 27.11. In terms of profitability, MSF.DE's ROE is +0.33%, compared to 3L7A.F's ROE of +0.39%. Regarding short-term risk, MSF.DE is less volatile compared to 3L7A.F. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check 3L7A.F's competition here
MSF.DE vs SOW.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, SOW.DE has a market cap of 2.7B. Regarding current trading prices, MSF.DE is priced at €459.50, while SOW.DE trades at €37.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas SOW.DE's P/E ratio is 161.30. In terms of profitability, MSF.DE's ROE is +0.33%, compared to SOW.DE's ROE of -0.00%. Regarding short-term risk, MSF.DE is less volatile compared to SOW.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check SOW.DE's competition here
MSF.DE vs SUSE.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, SUSE.DE has a market cap of 1.9B. Regarding current trading prices, MSF.DE is priced at €459.50, while SUSE.DE trades at €10.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas SUSE.DE's P/E ratio is -57.32. In terms of profitability, MSF.DE's ROE is +0.33%, compared to SUSE.DE's ROE of -0.02%. Regarding short-term risk, MSF.DE is more volatile compared to SUSE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check SUSE.DE's competition here
MSF.DE vs YSN.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, YSN.DE has a market cap of 1.5B. Regarding current trading prices, MSF.DE is priced at €459.50, while YSN.DE trades at €227.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas YSN.DE's P/E ratio is 52.55. In terms of profitability, MSF.DE's ROE is +0.33%, compared to YSN.DE's ROE of +0.41%. Regarding short-term risk, MSF.DE is less volatile compared to YSN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check YSN.DE's competition here
MSF.DE vs NFN.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, NFN.DE has a market cap of 106M. Regarding current trading prices, MSF.DE is priced at €459.50, while NFN.DE trades at €6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas NFN.DE's P/E ratio is 320.00. In terms of profitability, MSF.DE's ROE is +0.33%, compared to NFN.DE's ROE of +0.01%. Regarding short-term risk, MSF.DE is less volatile compared to NFN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check NFN.DE's competition here
MSF.DE vs EXL.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, EXL.DE has a market cap of 77.6M. Regarding current trading prices, MSF.DE is priced at €459.50, while EXL.DE trades at €2.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas EXL.DE's P/E ratio is 292.00. In terms of profitability, MSF.DE's ROE is +0.33%, compared to EXL.DE's ROE of +0.05%. Regarding short-term risk, MSF.DE is less volatile compared to EXL.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check EXL.DE's competition here
MSF.DE vs CYR.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, CYR.DE has a market cap of 44.4M. Regarding current trading prices, MSF.DE is priced at €459.50, while CYR.DE trades at €2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas CYR.DE's P/E ratio is -13.76. In terms of profitability, MSF.DE's ROE is +0.33%, compared to CYR.DE's ROE of -0.13%. Regarding short-term risk, MSF.DE is less volatile compared to CYR.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check CYR.DE's competition here
MSF.DE vs R1B.F Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, R1B.F has a market cap of 38.5M. Regarding current trading prices, MSF.DE is priced at €459.50, while R1B.F trades at €7.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas R1B.F's P/E ratio is -17.22. In terms of profitability, MSF.DE's ROE is +0.33%, compared to R1B.F's ROE of -0.21%. Regarding short-term risk, MSF.DE is less volatile compared to R1B.F. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check R1B.F's competition here
MSF.DE vs ABT.DU Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, ABT.DU has a market cap of 2.7M. Regarding current trading prices, MSF.DE is priced at €459.50, while ABT.DU trades at €0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas ABT.DU's P/E ratio is -13.20. In terms of profitability, MSF.DE's ROE is +0.33%, compared to ABT.DU's ROE of -0.08%. Regarding short-term risk, MSF.DE is more volatile compared to ABT.DU. This indicates potentially higher risk in terms of short-term price fluctuations for MSF.DE.Check ABT.DU's competition here
MSF.DE vs UMDK.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, UMDK.DE has a market cap of 1.4M. Regarding current trading prices, MSF.DE is priced at €459.50, while UMDK.DE trades at €0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas UMDK.DE's P/E ratio is -1.39. In terms of profitability, MSF.DE's ROE is +0.33%, compared to UMDK.DE's ROE of -0.15%. Regarding short-term risk, MSF.DE is less volatile compared to UMDK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check UMDK.DE's competition here
MSF.DE vs O5H.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, O5H.DE has a market cap of 400.8K. Regarding current trading prices, MSF.DE is priced at €459.50, while O5H.DE trades at €0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas O5H.DE's P/E ratio is -0.11. In terms of profitability, MSF.DE's ROE is +0.33%, compared to O5H.DE's ROE of -3.13%. Regarding short-term risk, MSF.DE is less volatile compared to O5H.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check O5H.DE's competition here
MSF.DE vs INW1.DE Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, INW1.DE has a market cap of 0. Regarding current trading prices, MSF.DE is priced at €459.50, while INW1.DE trades at €2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas INW1.DE's P/E ratio is -61.94. In terms of profitability, MSF.DE's ROE is +0.33%, compared to INW1.DE's ROE of -0.07%. Regarding short-term risk, MSF.DE is less volatile compared to INW1.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check INW1.DE's competition here
MSF.DE vs 50C.MU Comparison August 2025
MSF.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSF.DE stands at 3.4T. In comparison, 50C.MU has a market cap of 0. Regarding current trading prices, MSF.DE is priced at €459.50, while 50C.MU trades at €0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSF.DE currently has a P/E ratio of 37.73, whereas 50C.MU's P/E ratio is N/A. In terms of profitability, MSF.DE's ROE is +0.33%, compared to 50C.MU's ROE of N/A. Regarding short-term risk, MSF.DE is less volatile compared to 50C.MU. This indicates potentially lower risk in terms of short-term price fluctuations for MSF.DE.Check 50C.MU's competition here